Document Detail

Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
MedLine Citation:
PMID:  18805551     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Vein graft arterialization results in activation of the mitogen-activated protein kinases (MAPKs) extracellular signal-regulated kinases-1 and -2 (ERK1/2), which have been implicated in cell proliferation, migration, and apoptosis. The goal of our study was to characterize the effect of MAPK inhibition on intimal hyperplasia (IH) in arterialized vein grafts in hypercholesterolemic rabbits. METHODS: Reversed bilateral jugular vein to common carotid artery interposition grafts were constructed in 16 New Zealand White rabbits. The veins were incubated for 30 min prior to grafting with either the synthetic ERK1/2 activation inhibitor UO126 or the control vehicle. Vein graft and control jugular vein were harvested 3 h, 1 d, and 28 d after arterialization for histological and biochemical analyses. RESULTS: Treatment with UO126 was associated with 31% reduction in mean intimal area (1.68 +/- 0.78 mm(2)versus 2.44 +/- 1.65 mm(2); mean +/- SD; P = 0.036) relative to controls. The intima-to-media ratio of UO126-treated vein grafts decreased by 29% (0.53 +/- 0.04 versus 0.74 +/- 0.06; mean +/- SD; P < 0.01) compared to controls, vehicle-treated vein grafts. There was also significant increase in apoptosis in UO126-treated vein graft medial cell layer at 1 d. CONCLUSION: Topical administration of UO126 before vein grafting significantly decreases IH in arterialized vein grafts in hypercholesterolemic rabbits. These results may have significant implications for the development of strategies aimed at blocking or reducing IH in bypass grafts. Therefore, further evaluation of this simple strategy to improve vein graft patency following coronary artery or peripheral vascular bypass surgery is warranted.
Iosif Gulkarov; Katja Bohmann; Karma M Cinnante; Luigi Pirelli; Pey-Jen Yu; Juan B Grau; Giuseppe Pintucci; Aubrey C Galloway; Paolo Mignatti
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-05-09
Journal Detail:
Title:  The Journal of surgical research     Volume:  154     ISSN:  1095-8673     ISO Abbreviation:  J. Surg. Res.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-11     Completed Date:  2009-07-08     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0376340     Medline TA:  J Surg Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  150-6     Citation Subset:  IM    
The Seymour Cohn Cardiovascular Research Laboratory, Department of Cardiothoracic Surgery, New York University School of Medicine, New York, New York 10016, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Butadienes / therapeutic use*
Carotid Arteries / transplantation*
Carotid Artery, Common / surgery
Cell Division
Enzyme Activation / drug effects
Enzyme Inhibitors / therapeutic use*
Hyperplasia / prevention & control*
Jugular Veins / surgery*
Mitogen-Activated Protein Kinases / antagonists & inhibitors,  metabolism*
Nitriles / therapeutic use*
Tunica Intima / drug effects,  pathology*
Reg. No./Substance:
0/Butadienes; 0/Enzyme Inhibitors; 0/Nitriles; 0/U 0126; EC Protein Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bioimpedance analysis: a guide to simple design and implementation.
Next Document:  Use of scene vital signs improves TRISS predicted survival in intubated trauma patients.